BP781

Erythromycin

British Pharmacopoeia (BP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 114-07-8

Select a Size

Pack Size SKU Availability Price
100 MG BP781-100-MG In Stock ₹ 21,401.03

BP781 - 100 MG

₹ 21,401.03

In Stock

Quantity

1

Base Price: ₹ 21,401.03

GST (18%): ₹ 3,852.185

Total Price: ₹ 25,253.215

grade

pharmaceutical primary standard

API family

erythromycin

form

crystalline

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceuticalpharmaceutical small molecule

format

neat

storage temp.

−20°C

SMILES string

CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O

InChI

1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1

Other Options

Image Product Name Manufacturer Price Range
U.S. Pharmacopeia Erythromycin | 114-07-8 | MFCD00084654 | 250mg
-- ₹ 31,290.62
eMolecules​ Medchem Express / Erythromycin / 500mg / 491484411 / HY-B0220 / / 114-07-8 / [null] / 733.937 / C37H67NO13
-- ₹ 7,205.44
Erythromycin
-- ₹ 12,221.43
Erythromycin
-- ₹ 3,258.33 - ₹ 9,720.85
Erythromycin
-- ₹ 10,283.75 - ₹ 72,040.38
Erythromycin
-- ₹ 17,352.48 - ₹ 40,604.58
Erythromycin standard solution
-- ₹ 5,055.28
Erythromycin
-- ₹ 38,591.13
Erythromycin
-- ₹ 3,258.33 - ₹ 9,720.85
Erythromycin
-- ₹ 10,283.75 - ₹ 72,040.38

Related Products

Img

Sigma Aldrich

BP834

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

E1500800

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

BP885

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

D1800000

European Pharmacopoeia (EP) Referen...

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Erythromycin BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Erythromycin Ethyl Succinate TabletsErythromycin Stearate TabletsErythromycin Gastro-resistant CapsulesErythromycin Gastro-resistant TabletsErythromycin Lactobionate for InfusionErythromycin and Zinc Acetate Lotion
  • Biochem/physiol Actions: Mode of Action: Erythromycin acts by inhibiting elongation at the transpeptidation step, specifically aminoacyl translocation from the A-site to P-site by binding to the 50s subunit of the bacterial 70s rRNA complex.Antimicrobial Spectrum: This product acts against both gram-negative and gram-positive bacteria.
  • Packaging: Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable